newsfilter
← Latest News
GlobeNewswire·

Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH

GAITHERSBURG, Md., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing therapies that address serious liver diseases, today announced the U.S. Food